LeonaBio (LONA) Cash & Current Investments (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash & Current Investments data on file, last reported at $67.7 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 84.56% year-over-year to $67.7 million in Q1 2026; TTM through Mar 2026 was $67.7 million, a 84.56% increase from a year earlier, with the FY2025 full-year figure at $88.3 million, up 72.27% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $67.7 million, down from $88.3 million in the prior quarter.
• Over the last five years, Cash & Current Investments for LONA reached as high as $263.5 million in Q1 2022 and fell as low as $25.2 million in Q3 2025.
• Historically, Cash & Current Investments has averaged $130.0 million across 5 years, with a median of $122.1 million in 2024.
• Across the five-year window, Cash & Current Investments sank 69.96% in 2025 and jumped 84.56% in 2026, its largest moves.
• Year by year, Cash & Current Investments stood at $200.3 million in 2022, then decreased by 26.42% to $147.4 million in 2023, then slumped by 65.22% to $51.3 million in 2024, then jumped by 72.27% to $88.3 million in 2025, then decreased by 23.38% to $67.7 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $67.7 million in Q1 2026, $88.3 million in Q4 2025, and $25.2 million in Q3 2025.